Cell Press Reviews: Cancer Therapeutics

Cell Press Reviews: Cancer Therapeutics provides an overview of key recent advances and open research questions in cancer treatment. With articles written by leading researchers in the field, this publication offers the most up-to-date insights into how genetics influences treatment decisions and how the immune system can be employed to battle cancer, and describes the current state of the art in drug discovery and targeted treatments. Contributors to this compilation include many prominent researchers in the field, such as:
* Daniel A. Haber, Director, Massachusetts General Hospital Cancer Center; Professor, Harvard Medical School
* Tony Kouzarides, Professor, University of Cambridge; Deputy Director, Wellcome Trust/Cancer Research UK Gurdon Institute; founder, Chroma Therapeutics
* Charles L. Sawyers, Chair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center; President, American Association for Cancer Research; member, National Cancer Advisory Board; recipient, 2013 Breakthrough Prize in Life Sciences
Cell Press Reviews: Cancer Therapeutics will assist both experts and those new to the field in understanding the current state and future direction of cancer therapy.
This publication is part of the Cell Press Reviews series, which brings together topical review articles recently published in Cell Press journals, including the Trends in... series. These compilations are curated by Cell Press journal editors and offer comprehensive updates from leaders in the field on the most cutting-edge and important scientific questions.